333 related articles for article (PubMed ID: 35962190)
1. Virus-like particle vaccinology, from bench to bedside.
Mohsen MO; Bachmann MF
Cell Mol Immunol; 2022 Sep; 19(9):993-1011. PubMed ID: 35962190
[TBL] [Abstract][Full Text] [Related]
2. Virus-like Particle Vaccines and Platforms for Vaccine Development.
Kheirvari M; Liu H; Tumban E
Viruses; 2023 May; 15(5):. PubMed ID: 37243195
[TBL] [Abstract][Full Text] [Related]
3. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
4. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
5. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
Mohsen MO; Zha L; Cabral-Miranda G; Bachmann MF
Semin Immunol; 2017 Dec; 34():123-132. PubMed ID: 28887001
[TBL] [Abstract][Full Text] [Related]
6. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particles as powerful vaccination strategy against human viruses.
Hadj Hassine I; Ben M'hadheb M; Almalki MA; Gharbi J
Rev Med Virol; 2024 Jan; 34(1):e2498. PubMed ID: 38116958
[TBL] [Abstract][Full Text] [Related]
8. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
Eto Y; Saubi N; Ferrer P; Joseph J
AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
[TBL] [Abstract][Full Text] [Related]
9. Virus-Like Particle Vaccines Against Respiratory Viruses and Protozoan Parasites.
Chu KB; Quan FS
Curr Top Microbiol Immunol; 2021; 433():77-106. PubMed ID: 33650036
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of virus-like particles: a review.
Zeltins A
Mol Biotechnol; 2013 Jan; 53(1):92-107. PubMed ID: 23001867
[TBL] [Abstract][Full Text] [Related]
11. Engineering virus-like particles as vaccine platforms.
Frietze KM; Peabody DS; Chackerian B
Curr Opin Virol; 2016 Jun; 18():44-9. PubMed ID: 27039982
[TBL] [Abstract][Full Text] [Related]
12. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
13. Synthetic biology for bioengineering virus-like particle vaccines.
Charlton Hume HK; Vidigal J; Carrondo MJT; Middelberg APJ; Roldão A; Lua LHL
Biotechnol Bioeng; 2019 Apr; 116(4):919-935. PubMed ID: 30597533
[TBL] [Abstract][Full Text] [Related]
14. Virus like particle-based vaccines against emerging infectious disease viruses.
Liu J; Dai S; Wang M; Hu Z; Wang H; Deng F
Virol Sin; 2016 Aug; 31(4):279-87. PubMed ID: 27405928
[TBL] [Abstract][Full Text] [Related]
15. Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles.
Zhai L; Anderson D; Bruckner E; Tumban E
Protein Expr Purif; 2021 Nov; 187():105932. PubMed ID: 34214599
[TBL] [Abstract][Full Text] [Related]
16. Use of plant viruses and virus-like particles for the creation of novel vaccines.
Balke I; Zeltins A
Adv Drug Deliv Rev; 2019 May; 145():119-129. PubMed ID: 30172923
[TBL] [Abstract][Full Text] [Related]
17. Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ
Vaccine; 2020 May; 38(22):3892-3901. PubMed ID: 32284273
[TBL] [Abstract][Full Text] [Related]
18. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q
PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667
[TBL] [Abstract][Full Text] [Related]
19. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS
Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]